Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
Conditions
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- Recurrent Grade 3b Follicular Lymphoma
- Recurrent High Grade B-Cell Lymphoma
- Recurrent Primary Mediastinal Large B-Cell Lymphoma
- Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- Refractory Grade 3b Follicular Lymphoma
- Refractory High Grade B-Cell Lymphoma
- Refractory Primary Mediastinal Large B-Cell Lymphoma
- Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
- BIOLOGICAL: Odronextamab
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Bone Marrow Biopsy
- BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
- PROCEDURE: Computed Tomography
- PROCEDURE: Leukapheresis
- PROCEDURE: Lumbar Puncture
- PROCEDURE: Positron Emission Tomography
- OTHER: Questionnaire Administration
- PROCEDURE: Biopsy Procedure
Sponsor
University of Washington
Collaborators